Orange plunged to the bottom of France's CAC40 on renewed analyst scrutiny after Barclays returned to covering the stock with an Equal Weight rating. The bank's note said that the share price strength seen recently is largely reflected in Orange's valuation, leaving limited room for further upside.
On the market, Orange stock fell by roughly 4% to 16.81 euros, marking its weakest level in approximately three months.
Barclays' assessment of the deal and timing
Barclays welcomed the progress on a potential consolidation in the French telecom market. The analysts pointed to the June 6 memorandum of understanding in which Bouygues, Iliad and Orange agreed to acquire Altice SFR for a consideration of 820.35 billion. The bank assessed an "elevated probability of approval with limited remedies" from competition authorities, and noted that definitive legal documentation is expected in the second half of 2026, with completion targeted for the second half of 2027.
While the bidders have guided to annual cost synergies of 82 billion - a figure above Barclays' previous expectation - the bank revised its midpoint synergy estimate higher to 81.5 billion from 81.1 billion. Barclays qualified that increase by underscoring a limited scope for network rationalization, meaning its revised estimate still sits below the parties' stated target. The analysts also flagged that integration costs are likely to be higher than they had earlier assumed.
Valuation, leverage and cash flow dynamics
Despite the higher synergy guidance, Barclays argued that the price paid for the deal "fully captures the opex/capex synergies," and that any additional upside would depend on a longer-term market recovery. The bank's view implies that while there is scope for value creation if market conditions improve substantially, such a recovery would be distant and contingent on an uncertain macro and political environment in France.
The note highlighted rising leverage at Orange following its completed acquisition of MasOrange in Spain. Barclays estimated 2027 net debt to EBITDA at 2.5 times including hybrids, placing the group toward the higher end of its peer set - the bank's peer average for 2027 was cited at 2.2 times. On valuation multiples, Barclays said Orange trades roughly in line with peers on EV/EBITDA and EV/OpFCF for 2027, but at a discount on free cash flow yield, a gap the bank attributes in part to the company's higher leverage.
Barclays set a price target of 817 for Orange, noting that this figure incorporates part of the expected benefits from the transaction but leaves only limited upside from current levels. The analysts added that some of Orange's recent share price gains could reflect market uncertainty around other European telecom names, including Deutsche Telekom, which Barclays rates Overweight - a dynamic that could reverse and affect relative flows.
Analyst conclusion and market implications
Summing up their view, Barclays described the stock as having a "balanced risk/reward" at present valuation levels. The bank identified potential for upside if a broader market repair materializes, but cautioned that any such improvement would take time and depend on external macro-political conditions.
For investors and market participants, Barclays' return to coverage with an Equal Weight rating underscores a cautious stance: acknowledging deal-related synergies and potential long-term benefits while highlighting near-term valuation constraints, elevated leverage and integration cost risks that may constrain returns in the nearer term.